INJECTION INDEXWeight management, clearly.
The online care edition
October 2026
The plan index · October 2026

Semaglutide Injection Offers

Identify the product and compare the care and payment pathways.

Semaglutide is an ingredient name, not one universal online product. Wegovy is an approved branded medicine, while some providers advertise compounded preparations using semaglutide. These pathways differ in product status and should not be merged simply because a headline uses the same ingredient.

The entries below cover a published compounded offer, clinical membership models, and official branded information. A clinician should assess the actual product and the reader’s medical history. Use the review to learn what to confirm, then discuss the prescription before enrollment.

02

Noom Med

Plan-specific billing
The offer

Introductory and ongoing rates differ

A program with several treatment and billing tracks; identify your exact plan before comparing the headline.

Open the complete review →
Advertised pricePlan variesVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

03

Ro

Introductory membership
The offer

Membership and medication billed separately

Ro separates the cost of its care membership from the prescription cost.

Open the complete review →
Advertised price$39 startVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

04

Mochi Health

Membership only
The offer

Ongoing membership; medication costs extra

Mochi’s recurring membership and medicine charges need to be read together.

Open the complete review →
Advertised price$79/moVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

05

Wegovy

Branded medicine
The offer

Manufacturer medicine information; not a clinic

Wegovy is a branded semaglutide medicine record, not a clinic; its current forms, indications and savings terms must remain distinct from a provider’s package.

Open the complete review →
Advertised priceOffer variesVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

An approved product has its own information

Use the official Wegovy information for its indications and safety discussion. Clinical results are not promises for an individual, and they do not establish the performance of an unspecified compounded preparation. Read the Wegovy product profile for the source links.

A compounded offer needs an individual rationale

Ask why an approved medicine cannot meet your needs and which pharmacy supplies the preparation. Confirm the formulation and written directions. The product-status guide explains why a compounded product is not an FDA-approved generic.

Membership is not always the medicine price

A low care fee can leave the pharmacy expense separate. Match the product, supplied quantity, and normal renewal with the membership charges. The invoice worksheet turns those different figures into a useful comparison.

Explore the review directory and full cost table to compare the details of another offer.

Research record

Documents used

Official public information reviewed October 1, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.

  1. FDA: Concerns about unapproved GLP-1 drugs ↗
  2. NIDDK: Prescription medicines for weight management ↗
  3. Wegovy: Official product information ↗
  4. Zepbound: Official product information ↗
One more offer to explore

A clearly stated monthly price.

CoreAge Rx advertises compounded treatment with medication, supplies, and shipping together.

Semaglutide$99/month
Tirzepatide$149/month

No separate membership fee advertised.

Explore the CoreAge Rx plans ↗Open the full review →

A prescription and medical eligibility are required. Compounded medicines are not FDA-approved. Confirm the current offer and agreement with the provider.